Search company, investor...

Stage

Unattributed VC | Alive

Total Raised

$8.76M

Last Raised

$8.76M | 6 yrs ago

About ExploraMed V

ExploraMed is a medical technology incubation company dedicated to the identification, creation and development of medical device solutions. ExploraMed creates ideas in the fields of clinical, engineering, legal, strategic marketing, and financing, while focusing on efficient and timely development.

Headquarters Location

2570 W. El Camino Real Suite 310

Mountain View, California, 94040,

United States

650 472 0300

Loading...

Loading...

ExploraMed V Patents

ExploraMed V has filed 49 patents.

The 3 most popular patent topics include:

  • breastfeeding
  • infant feeding
  • babycare
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/23/2019

11/7/2023

Breastfeeding, Breast, Infant feeding, Breast milk, Infancy

Grant

Application Date

10/23/2019

Grant Date

11/7/2023

Title

Related Topics

Breastfeeding, Breast, Infant feeding, Breast milk, Infancy

Status

Grant

Latest ExploraMed V News

Obesity-Device Company Vibrynt Scraps IPO Plans, Looks to Sell

Feb 19, 2013

Timothy Hay, (c) 2013 Dow Jones & Company, Inc. (c) 2013 Dow Jones & Company, Inc. Vibrynt Inc., a graduate from prestigious medical-technology incubator ExploraMed that had at one time been expected to be one of Australia's largest initial public offerings, has put itself up for sale after scrapping its IPO plans over the high cost of U.S. clinical trials for its obesity-treatment devices, VentureWire has learned. "We have a product that works, and we have the data to prove that, said Chief Executive Beverly Huss. "It's a tragedy for this space. There is an obesity epidemic in this country, and great technologies can't reach the market."... Document DJFVW00020130219e92jaub78

ExploraMed V Frequently Asked Questions (FAQ)

  • Where is ExploraMed V's headquarters?

    ExploraMed V's headquarters is located at 2570 W. El Camino Real, Mountain View.

  • What is ExploraMed V's latest funding round?

    ExploraMed V's latest funding round is Unattributed VC.

  • How much did ExploraMed V raise?

    ExploraMed V raised a total of $8.76M.

  • Who are the investors of ExploraMed V?

    Investors of ExploraMed V include New Enterprise Associates.

  • Who are ExploraMed V's competitors?

    Competitors of ExploraMed V include Ivenix, Access Scientific, Stereotaxis, VytronUS, Vascular Pathways and 7 more.

Loading...

Compare ExploraMed V to Competitors

G
GRAFTcath

GRAFTcath is a medical device company developing vascular access products for hemodialysis.

Endothelix Logo
Endothelix

Endothelix is a company with a focus on non-invasive vascular function measurement within the cardiovascular device industry. Its main product, VENDYS, offers a non-invasive, FDA-approved test to assess endothelial function in a simple and cost-effective manner. The company markets its products to healthcare providers and patients, aiming to improve cardiovascular health diagnostics. It was founded in 2003 and is based in Houston, Texas.

P
Primaeva Medical

Primaeva Medical is an early stage medical device company developing a skin tightening and rejuvenation dermatological device

S
SonarMed

SonarMed is a company that focuses on the respiratory care sector. The company's main product is the SonarMed™ Airway Monitoring System, which provides continuous, precise, real-time monitoring of endotracheal tubes (ETTs), potentially helping to reduce unplanned extubations. The company primarily serves the healthcare industry, particularly in areas related to respiratory care. It was founded in 2005 and is based in Carmel, Indiana.

W
Windy Hill Medical

Windy Hill Medical is a medical device and pharmaceutical company focused on the development of products to reduce the risk of developing breast cancer in patients deemed to be at high risk.

O
Orthonics

Orthonicsis a company created through Georgia Tech's Venturlab program. Orthonics is developing biomaterials for orthopaedic tissue engineering applications. The company's core technology relates to biomaterials that permit in-growth and adhesion of bone and cartilage tissues. Initial applications will be spinal disc replacement and as aspinal disc annulus patch.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.